Literature DB >> 11354761

A rare cause of hyperprolactinemia: persistent trigeminal artery with stalk-section effect.

G Ekinci1, F Baltacioğlu, T Kiliç, C Cimşit, I Akpinar, N Pamir, C Erzen.   

Abstract

The primitive trigeminal, otic, hypoglossal, and proatlantal intersegmental arteries are fetal anastomoses between the carotid and vertebrobasilar systems. Persistent trigeminal artery (PTA) is the most frequent embryonic communication between the vertebrobasilar and carotid systems in adults. We report a case of PTA compressing the left side of the pituitary gland and stalk, in a patient with elevated blood prolactin level.

Entities:  

Mesh:

Year:  2001        PMID: 11354761     DOI: 10.1007/s003300000573

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  5 in total

Review 1.  Trigeminal artery: a review of normal and pathological features.

Authors:  Ljiljana Vasović; Ivan Jovanović; Slađana Ugrenović; Slobodan Vlajković; Predrag Jovanović; Vesna Stojanović
Journal:  Childs Nerv Syst       Date:  2011-11-10       Impact factor: 1.475

2.  Combined neuroform intracranial stent and bioactive matrix detachable coil for embolization of a broad-necked persistent primitive trigeminal artery aneurysm. A case report.

Authors:  Q P Zhao; T L Li; C Z Duan; G Z Chen
Journal:  Interv Neuroradiol       Date:  2005-06-17       Impact factor: 1.610

3.  Persistent primitive trigeminal artery: analysis of anatomical characteristics and clinical significances.

Authors:  Myeong Jin Kim; Myoung Soo Kim
Journal:  Surg Radiol Anat       Date:  2014-06-05       Impact factor: 1.246

4.  Anatomical features and clinical relevance of a persistent trigeminal artery.

Authors:  Gabriel Alcalá-Cerra; R S Tubbs; Lucía M Niño-Hernández
Journal:  Surg Neurol Int       Date:  2012-09-28

5.  Persistent trigeminal artery in a patient with posterior circulation stroke treated with rt-PA: case report.

Authors:  Axel Ferreira; Paulo S Coelho; Vítor Tedim Cruz
Journal:  BMC Neurol       Date:  2019-10-27       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.